John Hunter
Directeur Technique/Scientifique/R&D chez FIBROGEN, INC.
Profil
John Hunter is currently the Chief Scientific Officer at FibroGen, Inc. He previously worked as a Senior Director at XOMA Corp., Chief Scientific Officer at Compugen Ltd., Vice President-Antibody R&D at Compugen, Inc. (United States), and Chief Executive & Scientific Officer at Keyhole Therapeutics, Inc. Dr. Hunter received his undergraduate degree from Hartwick College and his doctorate from The University of California, San Francisco.
Postes actifs de John Hunter
| Sociétés | Poste | Début |
|---|---|---|
| FIBROGEN, INC. | Directeur Technique/Scientifique/R&D | 12/07/2021 |
Anciens postes connus de John Hunter
| Sociétés | Poste | Fin |
|---|---|---|
| XOMA ROYALTY CORPORATION | Directeur/Membre du Conseil | - |
| COMPUGEN LTD. | Directeur Technique/Scientifique/R&D | - |
| Keyhole Therapeutics, Inc. | Directeur Général | - |
| Compugen, Inc. (United States) | Corporate Officer/Principal | - |
Formation de John Hunter
| Hartwick College | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| XOMA ROYALTY CORPORATION | Health Technology |
| COMPUGEN LTD. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Compugen, Inc. (United States) | |
| Keyhole Therapeutics, Inc. |
